GLP-1 medications, including subcutaneous injections and tablets, have been a hot trend, followed by this new GLP-1 patch social media phenomenon
Dose 600 mg to 1200 mg per treatment and usually weekly or every other weeks with a practitioner
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
These restrictions also include substances that could cause dizziness, drowsiness or other side effects that compromise a pilots ability to perform safely
Market Segmentation Drug Type Insights (Revenue, USD BN, 2021 - 2033) Exenatide Liraglutide Sitagliptin Saxagliptin Alogliptin Others Disease Indication Insights (Revenue, USD BN, 2021 - 2033) Type 2 Diabetes Mellitus (T2DM) Weight Management Others Distribution Channel Insights (Revenue, USD BN, 2021 - 2033) Online Pharmacies Retail Pharmacies Hospital Pharmacies Regional Insights (Revenue, USD BN, 2021 - 2033) North America U.S
For example, Hashimoto's affects the thyroid, celiac disease involves the small intestine, and rheumatoid arthritis impacts the joints